We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.17B
AUM Growth
-$939M
Cap. Flow
-$328M
Cap. Flow %
-6.34%
Top 10 Hldgs %
49.51%
Holding
202
New
57
Increased
36
Reduced
26
Closed
61

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$121M
2
PTCT icon
PTC Therapeutics
PTCT
+$81.6M
3
VTRS icon
Viatris
VTRS
+$76.4M
4
TGT icon
Target
TGT
+$69.6M
5
FIVE icon
Five Below
FIVE
+$60.3M

Top Sells

Rank Stock Value
1
ASO icon
Academy Sports + Outdoors
ASO
+$66.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$62.3M
3
ULTA icon
Ulta Beauty
ULTA
+$62.1M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$59.8M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 45.3%
2 Consumer Staples 9.22%
3 Consumer Discretionary 6.86%
4 Technology 3.5%
5 Communication Services 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RL icon
176
Ralph Lauren
RL
$23.6B
– –
-189,084
Closed -$22.5M
RNG icon
177
RingCentral
RNG
$5.18B
– –
-79,000
Closed -$14.8M
RVPH
178
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
– –
-35,379
Closed -$2.04M
SAP icon
179
SAP
SAP
$230B
– –
-84,000
Closed -$11.8M
SWAG icon
180
Stran & Co
SWAG
$36.9M
– –
-804,829
Closed -$4.87M
TEAM icon
181
Atlassian
TEAM
$28B
– –
-43,000
Closed -$16.4M
TJX icon
182
TJX Companies
TJX
$179B
– –
-697,100
Closed -$52.9M
TLPH icon
183
Talphera
TLPH
$74.2M
– –
-418,250
Closed -$4.69M
TRVI icon
184
Trevi Therapeutics
TRVI
$2.63B
– –
-1,512,344
Closed -$1.18M
ULTA icon
185
Ulta Beauty
ULTA
$23.2B
– –
-150,639
Closed -$62.1M
WSM icon
186
Williams-Sonoma
WSM
$29.1B
– –
-82,676
Closed -$6.99M
XCUR icon
187
Exicure
XCUR
$8.6M
– –
-57,351
Closed -$1.74M
XRAY icon
188
Dentsply Sirona
XRAY
$2.64B
– –
-624,000
Closed -$34.8M
ZBH icon
189
Zimmer Biomet
ZBH
$18.8B
– –
-185,400
Closed -$22.9M
GTM
190
ZoomInfo Technologies
GTM
$1.22B
– –
-225,000
Closed -$14.4M
XTIA icon
191
XTI Aerospace
XTIA
$57.7M
– –
-4
Closed -$4.06M
SMAR
192
DELISTED
Smartsheet Inc.
SMAR
– –
-150,000
Closed -$11.6M
AXNX
193
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-388,000
Closed -$21.7M
SPLK
194
DELISTED
Splunk Inc
SPLK
– –
-60,000
Closed -$6.94M
ROI
195
DELISTED
RiskOn International, Inc. Common Stock
ROI
– –
-8,996
Closed -$602K
NSTG
196
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-536,000
Closed -$22.6M
TWNK
197
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
– –
-1,000,000
Closed -$20.4M
SCPS
198
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
– –
-2,100,000
Closed -$3.43M
ZEN
199
DELISTED
ZENDESK INC
ZEN
– –
-128,000
Closed -$13.3M
CRXT
200
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
– –
-1,929,876
Closed -$4.69M
5 6 7
8
9

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Armistice Capital held 202 positions worth $5.17B, down 15% from $6.11B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital withdrew a net $328M in Q1 2022, closing 61 positions and reducing 26 holdings. Its most notable exit was Academy Sports + Outdoors, an estimated $66.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in Home Depot worth $105M.

  • Armistice Capital's largest Q1 2022 buy was Home Depot: 349,897 shares worth $105M.
  • Armistice Capital added most to PTC Therapeutics in Q1 2022, an estimated $81.6M increase.
  • Armistice Capital's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $62.3M.
  • Armistice Capital fully exited Academy Sports + Outdoors in Q1 2022, selling an estimated $66.3M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.17B portfolio in Q1 2022.
  • Armistice Capital opened 57 new positions and closed 61 in Q1 2022.
  • Armistice Capital's portfolio value fell 15% quarter-over-quarter to $5.17B.

Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.